Trial Profile
The Chinese University of Hong Kong Early Arthritis Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Feb 2024
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Methotrexate
- Indications Atherosclerosis; Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ERA
- 15 Sep 2012 Results published in The Journal of Rheumatology.
- 09 Nov 2011 Results assessing the effect of treatment on arterial stiffness presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 27 May 2010 Planned end date changed from Sep 2010 to Dec 2011 as reported by ClinicalTrials.gov.